share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  07/09 16:17

Moomoo AI 已提取核心信息

On July 5, 2024, SeaStar Medical Holding Corporation, a Delaware-based company, was named as a defendant in a class action lawsuit filed by Forrest A K Wells, a purported shareholder. The lawsuit, filed in the United States District Court for the State of Colorado, alleges that SeaStar Medical and its management made material misstatements and omissions about the company's business operations and FDA approval processes for its product candidates. These allegations follow a restatement of the company's consolidated financial statements, which was disclosed in a Form 8-K filing on March 27, 2024. The lawsuit asserts claims under Section 10(b) and Section 20(a) of the Exchange Act, seeking compensatory and other damages. SeaStar Medical has announced its intention to vigorously defend against the claims. The company's common stock and warrants are listed on The Nasdaq Stock Market under the symbols ICU and ICUCW, respectively.
On July 5, 2024, SeaStar Medical Holding Corporation, a Delaware-based company, was named as a defendant in a class action lawsuit filed by Forrest A K Wells, a purported shareholder. The lawsuit, filed in the United States District Court for the State of Colorado, alleges that SeaStar Medical and its management made material misstatements and omissions about the company's business operations and FDA approval processes for its product candidates. These allegations follow a restatement of the company's consolidated financial statements, which was disclosed in a Form 8-K filing on March 27, 2024. The lawsuit asserts claims under Section 10(b) and Section 20(a) of the Exchange Act, seeking compensatory and other damages. SeaStar Medical has announced its intention to vigorously defend against the claims. The company's common stock and warrants are listed on The Nasdaq Stock Market under the symbols ICU and ICUCW, respectively.
2024年7月5日,总部设在特拉华州的SeaStar医疗控股公司被自称股东的Forrest A k Wells提起集体诉讼,被列为被告。诉讼提交至美国科罗拉多州联邦地区法院,声称SeaStar Medical及其管理层对公司业务操作及其产品候选的FDA批准工艺进行实质性的错误陈述和漏报。这些说法是在公司的综合财务报表重新编制后发现的,该报表披露于2024年3月27日的8-k表单中。诉讼声称追索《交易所法》第10(b)条及第20(a)条下的赔偿和其他损害。SeaStar医疗已经宣布其有意激烈反击这些指控。该公司的普通股和认股权证分别在纳斯达克证券交易所上市,代码分别为ICU和ICUCW。
2024年7月5日,总部设在特拉华州的SeaStar医疗控股公司被自称股东的Forrest A k Wells提起集体诉讼,被列为被告。诉讼提交至美国科罗拉多州联邦地区法院,声称SeaStar Medical及其管理层对公司业务操作及其产品候选的FDA批准工艺进行实质性的错误陈述和漏报。这些说法是在公司的综合财务报表重新编制后发现的,该报表披露于2024年3月27日的8-k表单中。诉讼声称追索《交易所法》第10(b)条及第20(a)条下的赔偿和其他损害。SeaStar医疗已经宣布其有意激烈反击这些指控。该公司的普通股和认股权证分别在纳斯达克证券交易所上市,代码分别为ICU和ICUCW。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息